n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Pulmonary Eosinophilia in 1 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
Pulmonary Eosinophilia: A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Komlósi, ZI | 1 |
Pozsonyi, E | 1 |
Tábi, T | 1 |
Szöko, E | 1 |
Nagy, A | 1 |
Bartos, B | 1 |
Kozma, GT | 1 |
Tamási, L | 1 |
Orosz, M | 1 |
Magyar, P | 1 |
Losonczy, G | 1 |
1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Pulmonary Eosinophilia
Article | Year |
---|---|
Lipopolysaccharide exposure makes allergic airway inflammation and hyper-responsiveness less responsive to dexamethasone and inhibition of iNOS.
Topics: Animals; Asthma; Bronchial Hyperreactivity; Cytokines; Dexamethasone; Drug Resistance; Female; Gluco | 2006 |